For the past 30 years, The Weinberg Group has assisted pharmaceutial and biotechnology clients in the
development and implementation of successful and innovative regulatory strategies. In addition, we
have worked with hundreds of companies to remediate, maintain and improve their regulatory compliance.
What makes us different?
We are experienced, privately held and totally independent.
Our project managers and consultants understand your business objectives
and commit to achieving them with you.
“What is the optimal regulatory strategy for my new small molecule?”
“Are you able to help us prepare the briefing package for a pre-IND meeting with FDA?”
“Can you complete 100 GCP audits across the world in the next six months?”
“How should I respond to a Warning Letter regarding issues at our manufacturing plant?”
“How can I estimate the regulatory risk of acquiring a new device?”
“We just acquired a new company. Can you provide a regulatory/ compliance assessment of its practices?”
Matthew Weinberg Writes for the International Clinical Trials (ICT) Magazine
In the August 2013 issue of ICT, CEO, Matthew Weinberg, wrote about the importance and rarity of independently audited clinical trials. To read the full article, please click here.
We are hiring!
The Weinberg Group is currently hiring for multiple positions, including: EU Business Development Professional, CMC Consultant, and Regulatory Affairs Consultant.